John McIlwraith - 26 Jan 2022 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC

Role
Director
Signature
/s/ F. Mark Reuter as Attorney-in-Fact for John C. McIlwraith
Issuer symbol
N/A
Transactions as of
26 Jan 2022
Net transactions value
$0
Form type
4
Filing time
28 Jan 2022, 10:37:49 UTC
Next filing
31 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIVO Common Stock Award $0 +3,012 +16% $0.000000 21,724 26 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIVO Stock Options (Right to Buy) Award $0 +5,656 $0.000000 5,656 26 Jan 2022 Common Stock 5,656 $20.75 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are awarded under the 2021 Omnibus Award Plan and vest in full (100%) on January 25, 2023.
F2 These options are awarded under the 2021 Omnibus Award Plan and vest in full (100%) on January 25, 2023.